AXGN

#2048
Axogen, Inc. Common Stock
34.7600 USD
+0.87%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
34.7600
34.7600
Intervallo Annuale
17.1400
35.9999
Variazione giornaliera
+0.87%
Variazione Mensile
+5.94%
Variazione di 6 mesi
+90.57%
Variazione Annuale
+90.57%
Chiusura Precedente
34.4600
Apertura
34.7600
Bid
Ask
Minimo
34.7600
High
34.7600
Volume
131
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 1.804 B
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-96.26
Rapporto prezzo/fatturato
6.69

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Notizie